Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Review

An update on extra-oral bitter taste receptors

Authors: Kamila Tuzim, Agnieszka Korolczuk

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Bitter taste-sensing type 2 receptors (TAS2Rs or T2Rs), belonging to the subgroup of family A G-protein coupled receptors (GPCRs), are of crucial importance in the perception of bitterness. Although in the first instance, TAS2Rs were considered to be exclusively distributed in the apical microvilli of taste bud cells, numerous studies have detected these sensory receptor proteins in several extra-oral tissues, such as in pancreatic or ovarian tissues, as well as in their corresponding malignancies. Critical points of extra-oral TAS2Rs biology, such as their structure, roles, signaling transduction pathways, extensive mutational polymorphism, and molecular evolution, have been currently broadly studied. The TAS2R cascade, for instance, has been recently considered to be a pivotal modulator of a number of (patho)physiological processes, including adipogenesis or carcinogenesis. The latest advances in taste receptor biology further raise the possibility of utilizing TAS2Rs as a therapeutic target or as an informative index to predict treatment responses in various disorders. Thus, the focus of this review is to provide an update on the expression and molecular basis of TAS2Rs functions in distinct extra-oral tissues in health and disease. We shall also discuss the therapeutic potential of novel TAS2Rs targets, which are appealing due to their ligand selectivity, expression pattern, or pharmacological profiles.
Literature
1.
Glendinning JI. Is the bitter rejection response always adaptive? Physiol Behav. 1994;56(6):1217–27.PubMed
2.
Mishra A, Chaturvedi P, Datta S, Sinukumar S, Joshi P, Garg A. Harmful effects of nicotine. Indian J Med Paediatr Oncol. 2015;36(1):24.PubMedPubMedCentral
3.
Xue AY, Di Pizio A, Levit A, et al. Independent evolution of strychnine recognition by bitter taste receptor subtypes. Front Mol Biosci. 2018;5:9.PubMedPubMedCentral
4.
5.
Chandrashekar J, Mueller KL, Hoon MA, et al. T2Rs function as bitter taste receptors. Cell. 2000;100(6):703–11.PubMed
6.
7.
Behrens M, Brockhoff A, Kuhn C, Bufe B, Winnig M, Meyerhof W. The human taste receptor hTAS2R14 responds to a variety of different bitter compounds. Biochem Biophys Res Commun. 2004;319(2):479–85.PubMed
8.
Miller IJ. Anatomy of the peripheral taste system. Handb Olfaction Gustation. 1995;521–47.
9.
Höfer D, Püschel B, Drenckhahn D. Taste receptor-like cells in the rat gut identified by expression of alpha-gustducin. Proc Natl Acad Sci U S A. 1996;93(13):6631–4.PubMedPubMedCentral
10.
Wu SV, Rozengurt N, Yang M, Young SH, Sinnett-Smith J, Rozengurt E. Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc Natl Acad Sci U S A. 2002;99(4):2392–7.PubMedPubMedCentral
11.
Finger TE, Böttger B, Hansen A, Anderson KT, Alimohammadi H, Silver WL. Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration. Proc Natl Acad Sci U S A. 2003;100(15):8981–6.PubMedPubMedCentral
12.
Lu P, Zhang C-H, Lifshitz LM, ZhuGe R. Extraoral bitter taste receptors in health and disease. J Gen Physiol. 2017;149(2):181–97.PubMedPubMedCentral
13.
Avau B, Depoortere I. The bitter truth about bitter taste receptors: beyond sensing bitter in the oral cavity. Acta Physiol (Oxf). 2016;216(4):407–20.
14.
Dagan-Wiener A, Di Pizio A, Nissim I, et al. BitterDB: taste ligands and receptors database in 2019. Nucleic Acids Res. 2019;47(D1):D1179–85.PubMed
15.
Kazius J, Wurdinger K, van Iterson M, Kok J, Bäck T, IJzerman AP. GPCR NaVa database: natural variants in human G protein-coupled receptors. Hum Mutat. 2008;29(1):39–44.PubMed
16.
Roudnitzky N, Behrens M, Engel A, et al. Receptor polymorphism and genomic structure interact to shape bitter taste perception. PLoS Genet. 2015;11(9): e1005530.PubMedPubMedCentral
17.
Adler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJP, Zuker CS. A novel family of mammalian taste receptors. Cell. 2000;100(6):693–702.PubMed
18.
Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJP, Zuker CS. Mammalian sweet taste receptors. Cell. 2001;106(3):381–90.PubMed
19.
Behrens M, Foerster S, Staehler F, Raguse J-D, Meyerhof W. Gustatory expression pattern of the human TAS2R bitter receptor gene family reveals a heterogenous population of bitter responsive taste receptor cells. J Neurosci. 2007;27(46):12630–40.PubMedPubMedCentral
20.
Wiener A, Shudler M, Levit A, Niv MY. BitterDB: a database of bitter compounds. Nucleic Acids Res. 2012;40(D1):D413–9.PubMed
21.
Yuan J, Peng G, Xiao G, et al. Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2-mediated glycolysis. J Cancer. 2020;11(14):4047.PubMedPubMedCentral
22.
Scagliarini A, Mathey A, Aires V, Delmas D. Xanthohumol, a prenylated flavonoid from hops, induces DNA damages in colorectal cancer cells and sensitizes SW480 cells to the SN38 chemotherapeutic agent. Cells. 2020;9(4):932.PubMedCentral
23.
Sławińska-Brych A, Zdzisińska B, Czerwonka A, et al. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production. Biochim Biophys Acta (BBA)-Gen Subj. 2019;1863(11): 129408.
24.
Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan M. Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PLoS ONE. 2019;14(3): e0213776.PubMedPubMedCentral
25.
Wei S, Sun T, Du J, Zhang B, Xiang D, Li W. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro. Oncol Rep. 2018;40(6):3213–22.PubMedPubMedCentral
26.
Carvalho DO, Freitas J, Nogueira P, et al. Xanthohumol inhibits cell proliferation and induces apoptosis in human thyroid cells. Food Chem Toxicol. 2018;121:450–7.PubMed
27.
Sun Z, Zhou C, Liu F, et al. Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro. Oncol Lett. 2018;15(1):908–16.PubMed
28.
Saito K, Matsuo Y, Imafuji H, et al. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Cancer Sci. 2018;109(1):132–40.PubMed
29.
Pu Q, Guo K, Lin P, et al. Bitter receptor TAS2R138 facilitates lipid droplet degradation in neutrophils during Pseudomonas aeruginosa infection. Signal Transduct Target Ther. 2021;6(1):1–10.
30.
Lee RJ, Xiong G, Kofonow JM, et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest. 2012;122(11):4145–59.PubMedPubMedCentral
31.
Medapati MR, Singh N, Bhagirath AY, et al. Bitter taste receptor T2R14 detects quorum sensing molecules from cariogenic Streptococcus mutans and mediates innate immune responses in gingival epithelial cells. FASEB J. 2021;35(3): e21375.PubMed
32.
Freund JR, Mansfield CJ, Doghramji LJ, et al. Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling. J Biol Chem. 2018;293(25):9824–40.PubMedPubMedCentral
33.
Carey RM, Workman AD, Chen B, et al. Staphylococcus aureus triggers nitric oxide production in human upper airway epithelium. In: International forum of allergy and rhinology. Wiley Online Library; p. 808–13.
34.
Carey RM, Chen B, Adappa ND, et al. Human upper airway epithelium produces nitric oxide in response to Staphylococcus epidermidis. In: International forum of allergy and rhinology. Wiley Online Library; p. 1238–44.
35.
Carey RM, Workman AD, Yan CH, et al. Sinonasal T2R-mediated nitric oxide production in response to Bacillus cereus. Am J Rhinol Allergy. 2017;31(4):211–5.PubMedPubMedCentral
36.
Verbeurgt C, Veithen A, Carlot S, et al. The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds. PLoS ONE. 2017;12(9): e0181302.PubMedPubMedCentral
37.
Clark AA, Liggett SB, Munger SD. Extraoral bitter taste receptors as mediators of off-target drug effects. FASEB J. 2012;26(12):4827–31.PubMedPubMedCentral
38.
Lossow K, Hübner S, Roudnitzky N, et al. Comprehensive analysis of mouse bitter taste receptors reveals different molecular receptive ranges for orthologous receptors in mice and humans. J Biol Chem. 2016;291(29):15358–77.PubMedPubMedCentral
39.
Meyerhof W, Batram C, Kuhn C, et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses. 2010;35(2):157–70.PubMed
40.
Risso DS, Kozlitina J, Sainz E, et al. Genetic variation in the TAS2R38 bitter taste receptor and smoking behaviors. PLoS ONE. 2016;11(10): e0164157.PubMedPubMedCentral
41.
Risso DS, Mezzavilla M, Pagani L, et al. Global diversity in the TAS2R38 bitter taste receptor: revisiting a classic evolutionary PROPosal. Sci Rep. 2016;6(1):1–9.
42.
Duffy VB. Variation in oral sensation: implications for diet and health. Curr Opin Gastroenterol. 2007;23(2):171–7.PubMed
43.
Dinehart ME, Hayes JE, Bartoshuk LM, Lanier SL, Duffy VB. Bitter taste markers explain variability in vegetable sweetness, bitterness, and intake. Physiol Behav. 2006;87(2):304–13.PubMed
44.
Hayes JE, Feeney EL, Nolden AA, McGeary JE. Quinine bitterness and grapefruit liking associate with allelic variants in TAS2R31. Chem Senses. 2015;40(6):437–43.PubMedPubMedCentral
45.
Allen AL, McGeary JE, Knopik VS, Hayes JE. Bitterness of the non-nutritive sweetener acesulfame potassium varies with polymorphisms in TAS2R9 and TAS2R31. Chem Senses. 2013;38(5):379–89.PubMedPubMedCentral
46.
Knaapila A, Hwang L-D, Lysenko A, et al. Genetic analysis of chemosensory traits in human twins. Chem Senses. 2012;37(9):869–81.PubMedPubMedCentral
47.
Reed DR, Zhu G, Breslin PAS, et al. The perception of quinine taste intensity is associated with common genetic variants in a bitter receptor cluster on chromosome 12. Hum Mol Genet. 2010;19(21):4278–85.PubMedPubMedCentral
48.
Hayes JE, Wallace MR, Knopik VS, Herbstman DM, Bartoshuk LM, Duffy VB. Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem Senses. 2011;36(3):311–9.PubMed
49.
Zhang Y, Hoon MA, Chandrashekar J, et al. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell. 2003;112(3):293–301.PubMed
50.
McLaughlin SK, McKinnon PJ, Margolskee RF. Gustducin is a taste-cell-specific G protein closely related to the transducins. Nature. 1992;357(6379):563–9.PubMed
51.
Rössler P, Kroner C, Freitag J, Noè J, Breer H. Identification of a phospholipase C β subtype in rat taste cells. Eur J Cell Biol. 1998;77(3):253–61.PubMed
52.
Wong GT, Gannon KS, Margolskee RF. Transduction of bitter and sweet taste by gustducin. Nature. 1996;381(6585):796–800.PubMed
53.
Ruiz CJ, Wray K, Delay E, Margolskee RF, Kinnamon SC. Behavioral evidence for a role of α-gustducin in glutamate taste. Chem Senses. 2003;28(7):573–9.PubMed
54.
Dotson CD, Roper SD, Spector AC. PLCβ2-independent behavioral avoidance of prototypical bitter-tasting ligands. Chem Senses. 2005;30(7):593–600.PubMed
55.
Pérez CA, Huang L, Rong M, et al. A transient receptor potential channel expressed in taste receptor cells. Nat Neurosci. 2002;5(11):1169–76.PubMed
56.
Damak S, Rong M, Yasumatsu K, et al. Trpm5 null mice respond to bitter, sweet, and umami compounds. Chem Senses. 2006;31(3):253–64.PubMed
57.
Zhang Z, Zhao Z, Margolskee R, Liman E. The transduction channel TRPM5 is gated by intracellular calcium in taste cells. J Neurosci. 2007;27(21):5777–86.PubMedPubMedCentral
58.
Banik DD, Martin LE, Freichel M, Torregrossa A-M, Medler KF. TRPM4 and TRPM5 are both required for normal signaling in taste receptor cells. Proc Natl Acad Sci U S A. 2018;115(4):E772–81.
59.
Taruno A, Vingtdeux V, Ohmoto M, et al. CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes. Nature. 2013;495(7440):223–6.PubMedPubMedCentral
60.
Ma Z, Taruno A, Ohmoto M, et al. CALHM3 is essential for rapid ion channel-mediated purinergic neurotransmission of GPCR-mediated tastes. Neuron. 2018;98(3):547–561. e10.
61.
Kinnamon SC. Neurosensory transmission without a synapse: new perspectives on taste signaling. BMC Biol. 2013;11(1):42.PubMedPubMedCentral
62.
Vandenbeuch A, Larson ED, Anderson CB, et al. Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in mice. J Physiol. 2015;593(5):1113–25.PubMedPubMedCentral
63.
Bystrova MF, Yatzenko YE, Fedorov IV, Rogachevskaja OA, Kolesnikov SS. P2Y isoforms operative in mouse taste cells. Cell Tissue Res. 2006;323(3):377–82.PubMed
64.
Huang YA, Dando R, Roper SD. Autocrine and paracrine roles for ATP and serotonin in mouse taste buds. J Neurosci. 2009;29(44):13909–18.PubMedPubMedCentral
65.
Kataoka S, Toyono T, Seta Y, Ogura T, Toyoshima K. Expression of P2Y 1 receptors in rat taste buds. Histochem Cell Biol. 2004;121(5):419–26.PubMed
66.
Deshpande DA, Wang WCH, McIlmoyle EL, et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med. 2010;16(11):1299.PubMedPubMedCentral
67.
68.
Grassin-Delyle S, Abrial C, Fayad-Kobeissi S, et al. The expression and relaxant effect of bitter taste receptors in human bronchi. Respir Res. 2013;14(1):134.PubMedPubMedCentral
69.
Tazzeo T, Bates G, Roman HN, et al. Caffeine relaxes smooth muscle through actin depolymerization. Am J Physiol Lung Cell Mol Physiol. 2012;303(4):L334–42.PubMedPubMedCentral
70.
Lund TC, Kobs AJ, Kramer A, et al. Bone marrow stromal and vascular smooth muscle cells have chemosensory capacity via bitter taste receptor expression. PLoS ONE. 2013;8(3): e58945.PubMedPubMedCentral
71.
Manson ML, Säfholm J, Al-Ameri M, et al. Bitter taste receptor agonists mediate relaxation of human and rodent vascular smooth muscle. Eur J Pharmacol. 2014;740:302–11.PubMed
72.
Upadhyaya JD, Singh N, Sikarwar AS, et al. Dextromethorphan mediated bitter taste receptor activation in the pulmonary circuit causes vasoconstriction. PLoS ONE. 2014;9(10): e110373.PubMedPubMedCentral
73.
Zhai K, Yang Z, Zhu X, et al. Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptoms. Oncotarget. 2016;7(16):21156.PubMedPubMedCentral
74.
75.
Saunders CJ, Christensen M, Finger TE, Tizzano M. Cholinergic neurotransmission links solitary chemosensory cells to nasal inflammation. Proc Natl Acad Sci U S A. 2014;111(16):6075–80.PubMedPubMedCentral
76.
Barham HP, Cooper SE, Anderson CB, et al. Solitary chemosensory cells and bitter taste receptor signaling in human sinonasal mucosa. In: International forum of allergy and rhinology. Wiley Online Library; p. 450–7.
77.
Lee RJ, Kofonow JM, Rosen PL, et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest. 2014;124(3):1393–405.PubMedPubMedCentral
78.
Tizzano M, Gulbransen BD, Vandenbeuch A, et al. Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc Natl Acad Sci U S A. 2010;107(7):3210–5.PubMedPubMedCentral
79.
Hatten KM, Palmer JN, Lee RJ, Adappa ND, Kennedy DW, Cohen NA. Nasal mucus glucose and chronic rhinosinusitis. Otolaryngol Head Neck Surg (1979). 2014;151(1_suppl):124.
80.
Garnett JP, Baker EH, Baines DL. Sweet talk: insights into the nature and importance of glucose transport in lung epithelium. Eur Respir J. 2012;40(5):1269–76.PubMed
81.
Gill SK, Hui K, Farne H, et al. Increased airway glucose increases airway bacterial load in hyperglycaemia. Sci Rep. 2016;6(1):1–10.
82.
Workman AD, Maina IW, Brooks SG, et al. The role of quinine-responsive taste receptor family 2 in airway immune defense and chronic rhinosinusitis. Front Immunol. 2018;9:624.PubMedPubMedCentral
83.
Yan CH, Hahn S, McMahon D, et al. Nitric oxide production is stimulated by bitter taste receptors ubiquitously expressed in the sinonasal cavity. Am J Rhinol Allergy. 2017;31(2):85–92.PubMedPubMedCentral
84.
Adappa ND, Howland TJ, Palmer JN, et al. Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. In: International forum of allergy and rhinology. Wiley Online Library; p. 184–7.
85.
Adappa ND, Zhang Z, Palmer JN, et al. The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. In: International forum of allergy and rhinology. Wiley Online Library; p. 3–7.
86.
Mfuna Endam L, Filali‐Mouhim A, Boisvert P, Boulet L, Bossé Y, Desrosiers M. Genetic variations in taste receptors are associated with chronic rhinosinusitis: a replication study. In: International forum of allergy and rhinology. Wiley Online Library; p. 200–6.
87.
Adappa ND, Farquhar D, Palmer JN, et al. TAS2R38 genotype predicts surgical outcome in nonpolypoid chronic rhinosinusitis. In: International forum of allergy and rhinology. Wiley Online Library; p. 25–33.
88.
Adappa ND, Workman AD, Hadjiliadis D, et al. T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients. In: International forum of allergy & rhinology. Wiley Online Library; p. 356–61.
89.
Kim U, Jorgenson E, Coon H, Leppert M, Risch N, Drayna D. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science (80-). 2003;299(5610):1221–5.
90.
Gallo S, Grossi S, Montrasio G, et al. TAS2R38 taste receptor gene and chronic rhinosinusitis: new data from an Italian population. BMC Med Genet. 2016;17(1):54.PubMedPubMedCentral
91.
Karunasagar A, Garag SS, Appannavar SB, Kulkarni RD, Naik AS. Bacterial biofilms in chronic rhinosinusitis and their implications for clinical management. Indian J Otolaryngol Head Neck Surg. 2018;70(1):43–8.PubMed
92.
Cantone E, Negri R, Roscetto E, et al. In vivo biofilm formation, gram-negative infections and TAS 2 R 38 polymorphisms in CRS w NP patients. Laryngoscope. 2018;128(10):E339–45.PubMed
93.
Adappa ND, Truesdale CM, Workman AD, et al. Correlation of T2R38 taste phenotype and in vitro biofilm formation from nonpolypoid chronic rhinosinusitis patients. In: International forum of allergy and rhinology. Wiley Online Library; p. 783–91.
94.
Safi C, Zheng Z, Dimango E, Keating C, Gudis DA. Chronic rhinosinusitis in cystic fibrosis: diagnosis and medical management. Med Sci. 2019;7(2):32.
95.
Castaldo A, Cernera G, Iacotucci P, et al. TAS2R38 is a novel modifier gene in patients with cystic fibrosis. Sci Rep. 2020;10(1):1–6.
96.
Shah AS, Ben-Shahar Y, Moninger TO, Kline JN, Welsh MJ. Motile cilia of human airway epithelia are chemosensory. Science (80-). 2009;325(5944):1131–4.
97.
Krasteva G, Canning BJ, Hartmann P, et al. Cholinergic chemosensory cells in the trachea regulate breathing. Proc Natl Acad Sci U S A. 2011;108(23):9478–83.PubMedPubMedCentral
98.
Pulkkinen V, Manson ML, Säfholm J, Adner M, Dahlén S-E. The bitter taste receptor (TAS2R) agonists denatonium and chloroquine display distinct patterns of relaxation of the guinea pig trachea. Am J Physiol Lung Cell Mol Physiol. 2012;303(11):L956–66.PubMed
99.
Deshpande DA, Robinett KS, Wang WCH, Sham JSK, An SS, Liggett SB. Bronchodilator activity of bitter tastants in human tissue. Nat Med. 2011;17(7):776–8.PubMedPubMedCentral
100.
Robinett KS, Koziol-White CJ, Akoluk A, An SS, Panettieri RA Jr, Liggett SB. Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells. Am J Respir Cell Mol Biol. 2014;50(4):678–83.PubMedPubMedCentral
101.
An SS, Wang WCH, Koziol-White CJ, et al. TAS2R activation promotes airway smooth muscle relaxation despite β2-adrenergic receptor tachyphylaxis. Am J Physiol Lung Cell Mol Physiol. 2012;303(4):L304–11.PubMedPubMedCentral
102.
Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the β2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000;162(1):75–80.PubMed
103.
Yoon S-Y, Shin E-S, Park SY, et al. Association between polymorphisms in bitter taste receptor genes and clinical features in Korean asthmatics. Respiration. 2016;91(2):141–50.PubMed
104.
Tan X, Sanderson MJ. Bitter tasting compounds dilate airways by inhibiting airway smooth muscle calcium oscillations and calcium sensitivity. Br J Pharmacol. 2014;171(3):646–62.PubMedPubMedCentral
105.
106.
107.
Sharma P, Panebra A, Pera T, et al. Antimitogenic effect of bitter taste receptor agonists on airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2016;310(4):L365–76.PubMed
108.
Kim D, Cho S, Castaño MA, Panettieri RA, Woo JA, Liggett SB. Biased TAS2R bronchodilators inhibit airway smooth muscle growth by downregulating phosphorylated extracellular signal-regulated kinase 1/2. Am J Respir Cell Mol Biol. 2019;60(5):532–40.PubMedPubMedCentral
109.
Pan S, Sharma P, Shah SD, Deshpande DA. Bitter taste receptor agonists alter mitochondrial function and induce autophagy in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2017;313(1):L154–65.PubMedPubMedCentral
110.
Orsmark-Pietras C, James A, Konradsen JR, et al. Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics. Eur Respir J. 2013;42(1):65–78.PubMed
111.
Ekoff M, Choi J-H, James A, Dahlén B, Nilsson G, Dahlén S-E. Bitter taste receptor (TAS2R) agonists inhibit IgE-dependent mast cell activation. J Allergy Clin Immunol. 2014;134(2):475–8.PubMed
112.
Grassin Delyle S, Abrial C, Brollo M, Fayad-Kobeissi S, Naline E, Devillier P. Characterization of the expression and the role of bitter taste receptors in human lung parenchyma and macrophages. In: D36 sepsis, acute respiratory distress syndrome, and acute lung injury. American Thoracic Society; 2014. p. A5749–A5749.
113.
Malki A, Fiedler J, Fricke K, Ballweg I, Pfaffl MW, Krautwurst D. Class I odorant receptors, TAS1R and TAS2R taste receptors, are markers for subpopulations of circulating leukocytes. J Leukoc Biol. 2015;97(3):533–45.PubMedPubMedCentral
114.
Maurer S, Wabnitz GH, Kahle NA, et al. Tasting Pseudomonas aeruginosa biofilms: human neutrophils express the bitter receptor T2R38 as sensor for the quorum sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone. Front Immunol. 2015;6:369.PubMedPubMedCentral
115.
Gaida MM, Dapunt U, Hänsch GM. Sensing developing biofilms: the bitter receptor T2R38 on myeloid cells. Pathog Dis. 2016;74(3):ftw004.PubMedPubMedCentral
116.
Tran HTT, Herz C, Ruf P, Stetter R, Lamy E. Human T2R38 bitter taste receptor expression in resting and activated lymphocytes. Front Immunol. 2018;9:2949.PubMedPubMedCentral
117.
Gopallawa I, Freund JR, Lee RJ. Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling. Cell Mol Life Sci. 2020;1–16.
118.
119.
Pinti M, Appay V, Campisi J, et al. Aging of the immune system: focus on inflammation and vaccination. Eur J Immunol. 2016;46(10):2286–301.PubMedPubMedCentral
120.
Voigt A, Hübner S, Lossow K, Hermans-Borgmeyer I, Boehm U, Meyerhof W. Genetic labeling of Tas1r1 and Tas2r131 taste receptor cells in mice. Chem Senses. 2012;37(9):897–911.PubMed
121.
Panneck AR, Rafiq A, Schütz B, et al. Cholinergic epithelial cell with chemosensory traits in murine thymic medulla. Cell Tissue Res. 2014;358(3):737–48.PubMedPubMedCentral
122.
Soultanova A, Voigt A, Chubanov V, et al. Cholinergic chemosensory cells of the thymic medulla express the bitter receptor Tas2r131. Int Immunopharmacol. 2015;29(1):143–7.PubMed
123.
Zhang Y, Wang X, Li X, et al. Identification of a specific agonist of human TAS2R14 from Radix Bupleuri through virtual screening, functional evaluation and binding studies. Sci Rep. 2017;7(1):1–12.
124.
Grassin-Delyle S, Salvator H, Mantov N, et al. Bitter taste receptors (TAS2Rs) in human lung macrophages: receptor expression and inhibitory effects of TAS2R agonists. Front Physiol. 2019;10:1267.PubMedPubMedCentral
125.
Wölfle U, Elsholz FA, Kersten A, Haarhaus B, Schumacher U, Schempp CM. Expression and functional activity of the human bitter taste receptor TAS2R38 in human placental tissues and JEG-3 cells. Molecules. 2016;21(3):306.PubMedPubMedCentral
126.
Taher S, Borja Y, Cabanela L, et al. Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling. Am J Physiol Regul Integr Comp Physiol. 2019;316(5):R628–39.PubMedPubMedCentral
127.
Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction. 2011;141(6):715–24.PubMed
128.
129.
Shah N. The in vitro interrogation of the immune system in pregnancy. London: Imperial College London; 2016.
130.
Klaffenbach D, Friedrich D, Strick R, et al. Contribution of different placental cells to the expression and stimulation of antimicrobial proteins (AMPs). Placenta. 2011;32(11):830–7.PubMed
131.
Dietrich CG, Geier A, Elferink RPJO. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut. 2003;52(12):1788–95.PubMedPubMedCentral
132.
Han LW, Gao C, Mao Q. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Expert Opin Drug Metab Toxicol. 2018;14(8):817–29.PubMedPubMedCentral
133.
Jeon T-I, Seo Y-K, Osborne TF. Gut bitter taste receptor signalling induces ABCB1 through a mechanism involving CCK. Biochem J. 2011;438(1):33–7.PubMed
134.
Zheng K, Lu P, Delpapa E, et al. Bitter taste receptors as targets for tocolytics in preterm labor therapy. FASEB J. 2017;31(9):4037–52.PubMedPubMedCentral
135.
Xu J, Cao J, Iguchi N, Riethmacher D, Huang L. Functional characterization of bitter-taste receptors expressed in mammalian testis. Mol Hum Reprod. 2012;19(1):17–28.PubMedPubMedCentral
136.
Li F, Zhou M. Depletion of bitter taste transduction leads to massive spermatid loss in transgenic mice. Mol Hum Reprod. 2012;18(6):289–97.PubMedPubMedCentral
137.
Governini L, Semplici B, Pavone V, et al. Expression of taste receptor 2 subtypes in human testis and sperm. J Clin Med. 2020;9(1):264.PubMedCentral
138.
Gentiluomo M, Crifasi L, Luddi A, et al. Taste receptor polymorphisms and male infertility. Hum Reprod. 2017;32(11):2324–31.PubMed
139.
Kok BP, Galmozzi A, Littlejohn NK, et al. Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits. Mol Metab. 2018;16:76–87.PubMedPubMedCentral
140.
Bezençon C, Fürholz A, Raymond F, et al. Murine intestinal cells expressing Trpm5 are mostly brush cells and express markers of neuronal and inflammatory cells. J Comp Neurol. 2008;509(5):514–25.PubMed
141.
Clavenzani P, De Giorgio R, Mazzoni M, et al. Expression of alpha-transducin, a chemoreceptive molecule, in endocrine and non-endocrine cells of the pig gastrointestinal tract. Vet Res Commun. 2009;33(Suppl 1):85–7.PubMedPubMedCentral
142.
Luo X-C, Chen Z-H, Xue J-B, et al. Infection by the parasitic helminth Trichinella spiralis activates a Tas2r-mediated signaling pathway in intestinal tuft cells. Proc Natl Acad Sci. 2019;116(12):5564–9.PubMedPubMedCentral
143.
Gerbe F, Sidot E, Smyth DJ, et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature. 2016;529(7585):226–30.PubMed
144.
Howitt MR, Lavoie S, Michaud M, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science (80-). 2016;351(6279):1329–33.
145.
von Moltke J, Ji M, Liang H-E, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2–epithelial response circuit. Nature. 2016;529(7585):221–5.
146.
Prandi S, Bromke M, Hübner S, et al. A subset of mouse colonic goblet cells expresses the bitter taste receptor Tas2r131. PLoS ONE. 2013;8(12):e82820.PubMedPubMedCentral
147.
Prandi S, Voigt A, Meyerhof W, Behrens M. Expression profiling of Tas2r genes reveals a complex pattern along the mouse GI tract and the presence of Tas2r131 in a subset of intestinal Paneth cells. Cell Mol Life Sci. 2018;75(1):49–65.PubMed
148.
Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw. 2017;17(1):25–40.PubMedPubMedCentral
149.
Turner A, Chijoff E, Veysey M, et al. Interactions between taste receptors and the gastrointestinal microbiome in inflammatory bowel disease. J Nutr Intermed Metab. 2019;18: 100106.
150.
Chamoun E, Mutch DM, Allen-Vercoe E, et al. A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health. Crit Rev Food Sci Nutr. 2018;58(2):194–207.PubMed
151.
Feng P, Chai J, Yi H, et al. Aggravated gut inflammation in mice lacking the taste signaling protein α-gustducin. Brain Behav Immun. 2018;71:23–7.PubMedPubMedCentral
152.
153.
Cao SS. Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(3):636–44.PubMed
154.
Kunde DA, Chong WC, Nerurkar PV, et al. Bitter melon protects against ER stress in LS174T colonic epithelial cells. BMC Complement Altern Med. 2017;17(1):2.PubMedPubMedCentral
155.
Janssen S, Laermans J, Verhulst P-J, Thijs T, Tack J, Depoortere I. Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci U S A. 2011;108(5):2094–9.PubMedPubMedCentral
156.
Deloose E, Corsetti M, Van Oudenhove L, Depoortere I, Tack J. Intragastric infusion of the bitter tastant quinine suppresses hormone release and antral motility during the fasting state in healthy female volunteers. Neurogastroenterol Motil. 2018;30(1): e13171.
157.
Iven J, Biesiekierski JR, Zhao D, et al. Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms. Nutr Neurosci. 2019;22(12):850–62.PubMed
158.
Andreozzi P, Sarnelli G, Pesce M, et al. The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects. J Neurogastroenterol Motil. 2015;21(4):511.PubMedPubMedCentral
159.
160.
Chen MC, Wu SV, Reeve JR Jr, Rozengurt E. Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels. Am J Physiol Cell Physiol. 2006;291(4):C726–39.PubMed
161.
Zhang S, Ma Y, Li J, Ma J, Yu B, Xie X. Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder. Proc Natl Acad Sci U S A. 2014;111(40):14571–6.PubMedPubMedCentral
162.
Le Nevé B, Foltz M, Daniel H, Gouka R. The steroid glycoside Hg-12 from Hoodia gordonii activates the human bitter receptor TAS2R14 and induces CCK release from HuTu-80 cells. Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1368–75.PubMed
163.
Hao S, Dulake M, Espero E, Sternini C, Raybould HE, Rinaman L. Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol. 2009;296(3):R528–36.PubMed
164.
Hao S, Sternini C, Raybould HE. Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol. 2008;294(1):R33–8.PubMed
165.
Jeon T-I, Zhu B, Larson JL, Osborne TF. SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. J Clin Invest. 2008;118(11):3693–700.PubMedPubMedCentral
166.
Kaji I, Karaki S, Fukami Y, Terasaki M, Kuwahara A. Secretory effects of a luminal bitter tastant and expressions of bitter taste receptors, T2Rs, in the human and rat large intestine. Am J Physiol Gastrointest Liver Physiol. 2009;296(5):G971–81.PubMed
167.
Donnelly D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol. 2012;166(1):27–41.PubMedPubMedCentral
168.
Yue X, Liang J, Gu F, Du D, Chen F. Berberine activates bitter taste responses of enteroendocrine STC-1 cells. Mol Cell Biochem. 2018;447(1–2):21–32.PubMed
169.
Yu Y, Hao G, Zhang Q, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol. 2015;97(2):173–7.PubMed
170.
Pham H, Hui H, Morvaridi S, et al. A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells. Biochem Biophys Res Commun. 2016;475(3):295–300.PubMedPubMedCentral
171.
172.
Kim K-S, Egan JM, Jang H-J. Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways. Diabetologia. 2014;57(10):2117–25.PubMedPubMedCentral
173.
Suh H-W, Lee K-B, Kim K-S, et al. A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse. J Ethnopharmacol. 2015;172:219–26.PubMed
174.
Glendinning JI, Yiin Y-M, Ackroff K, Sclafani A. Intragastric infusion of denatonium conditions flavor aversions and delays gastric emptying in rodents. Physiol Behav. 2008;93(4–5):757–65.PubMed
175.
Avau B, Rotondo A, Thijs T, et al. Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation. Sci Rep. 2015;5:15985.PubMedPubMedCentral
176.
Avau B, Bauters D, Steensels S, et al. The gustatory signaling pathway and bitter taste receptors affect the development of obesity and adipocyte metabolism in mice. PLoS ONE. 2015;10(12): e0145538.PubMedPubMedCentral
177.
Latorre R, Huynh J, Mazzoni M, et al. Expression of the bitter taste receptor, T2R38, in enteroendocrine cells of the colonic mucosa of overweight/obese vs lean subjects. PLoS ONE. 2016;11(2): e0147468.PubMedPubMedCentral
178.
Mennella I, Fogliano V, Ferracane R, Arlorio M, Pattarino F, Vitaglione P. Microencapsulated bitter compounds (from Gentiana lutea) reduce daily energy intakes in humans. Br J Nutr. 2016;116(10):1841–50.
179.
Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475–90.PubMed
180.
Barbarossa IT, Carta G, Murru E, et al. Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals. Nutrition. 2013;29(3):531–6.
181.
Tepper BJ, Banni S, Melis M, Crnjar R, Tomassini BI. Genetic sensitivity to the bitter taste of 6-n-propylthiouracil (PROP) and its association with physiological mechanisms controlling body mass index (BMI). Nutrients. 2014;6(9):3363–81.PubMedPubMedCentral
182.
Hass N, Schwarzenbacher K, Breer H. A cluster of gustducin-expressing cells in the mouse stomach associated with two distinct populations of enteroendocrine cells. Histochem Cell Biol. 2007;128(5):457–71.PubMed
183.
Sutherland K, Young RL, Cooper NJ, Horowitz M, Blackshaw LA. Phenotypic characterization of taste cells of the mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;292(5):G1420–8.PubMed
184.
Carlson AJ. The control of hunger in health and disease. AJN Am J Nurs. 1917;17(4):373.
185.
Andrews CN, Verschueren S, Janssen P, et al. Su2072 the bitter taste receptor agonist denatonium benzoate alters intragastric pressure profiles during nutrient drink test in healthy volunteers. Gastroenterology. 2013;144(5):S-549.
186.
Deloose E, Janssen P, Corsetti M, et al. Intragastric infusion of denatonium benzoate attenuates interdigestive gastric motility and hunger scores in healthy female volunteers. Am J Clin Nutr. 2017;105(3):580–8.PubMed
187.
Mazzoni M, De Giorgio R, Latorre R, et al. Expression and regulation of α-transducin in the pig gastrointestinal tract. J Cell Mol Med. 2013;17(4):466–74.PubMedPubMedCentral
188.
Vegezzi G, Anselmi L, Huynh J, et al. Diet-induced regulation of bitter taste receptor subtypes in the mouse gastrointestinal tract. PLoS ONE. 2014;9(9): e107732.PubMedPubMedCentral
189.
Singh N, Vrontakis M, Parkinson F, Chelikani P. Functional bitter taste receptors are expressed in brain cells. Biochem Biophys Res Commun. 2011;406(1):146–51.PubMed
190.
Dehkordi O, Rose JE, Fatemi M, et al. Neuronal expression of bitter taste receptors and downstream signaling molecules in the rat brainstem. Brain Res. 2012;1475:1–10.PubMed
191.
Tomás J, Santos CRA, Quintela T, Gonçalves I. “Tasting” the cerebrospinal fluid: another function of the choroid plexus? Neuroscience. 2016;320:160–71.PubMed
192.
Chao DHM, Argmann C, Van Eijk M, et al. Impact of obesity on taste receptor expression in extra-oral tissues: emphasis on hypothalamus and brainstem. Sci Rep. 2016;6:29094.
193.
194.
Upadhyaya J, Pydi SP, Singh N, Aluko RE, Chelikani P. Bitter taste receptor T2R1 is activated by dipeptides and tripeptides. Biochem Biophys Res Commun. 2010;398(2):331–5.PubMed
195.
Li Y, Yu L, Zhao L, Zeng F, Liu Q. Resveratrol modulates cocaine-induced inhibitory synaptic plasticity in VTA dopamine neurons by inhibiting phosphodiesterases (PDEs). Sci Rep. 2017;7(1):1–10.
196.
Raygude KS, Kandhare AD, Ghosh P, Bodhankar SL. Anticonvulsant effect of fisetin by modulation of endogenous biomarkers. Biomed Prev Nutr. 2012;2(3):215–22.
197.
Jhaveri N, Cho H, Torres S, et al. Noscapine inhibits tumor growth in TMZ-resistant gliomas. Cancer Lett. 2011;312(2):245–52.PubMed
198.
199.
Seo Y, Kim Y-S, Lee KE, Park TH, Kim Y. Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells. PLoS ONE. 2017;12(5): e0176851.PubMedPubMedCentral
200.
Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E, Ferrer I. Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience. 2013;248:369–82.PubMed
201.
Garcia-Esparcia P, Schlüter A, Carmona M, et al. Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol. 2013;72(6):524–39.PubMed
202.
Ansoleaga B, Garcia-Esparcia P, Pinacho R, Haro JM, Ramos B, Ferrer I. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia. J Psychiatr Res. 2015;60:109–16.PubMed
203.
Foster SR, Porrello ER, Purdue B, et al. Expression, regulation and putative nutrient-sensing function of taste GPCRs in the heart. PLoS ONE. 2013;8(5): e64579.PubMedPubMedCentral
204.
Foster SR, Porrello ER, Stefani M, et al. Cardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation. Naunyn-Schmiedebergs Arch Pharmacol. 2015;388(10):1009–27.PubMed
205.
Foster SR, Blank K, See Hoe LE, et al. Bitter taste receptor agonists elicit G-protein-dependent negative inotropy in the murine heart. FASEB J. 2014;28(10):4497–508.PubMed
206.
Shiffman D, O’Meara ES, Bare LA, et al. Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2008;28(1):173–9.PubMed
207.
Akao H, Polisecki E, Kajinami K, et al. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly. Atherosclerosis. 2012;220(2):456–62.PubMed
208.
Chen J-G, Ping N-N, Liang D, et al. The expression of bitter taste receptors in mesenteric, cerebral and omental arteries. Life Sci. 2017;170:16–24.PubMed
209.
Rajkumar P, Aisenberg WH, Acres OW, Protzko RJ, Pluznick JL. Identification and characterization of novel renal sensory receptors. PLoS ONE. 2014;9(10): e111053.PubMedPubMedCentral
210.
Liu X, Gu F, Jiang L, Chen F, Li F. Expression of bitter taste receptor Tas2r105 in mouse kidney. Biochem Biophys Res Commun. 2015;458(4):733–8.PubMed
211.
Liang J, Chen F, Gu F, Liu X, Li F, Du D. Expression and functional activity of bitter taste receptors in primary renal tubular epithelial cells and M-1 cells. Mol Cell Biochem. 2017;428(1–2):193–202.PubMed
212.
Wooding SP, Atanasova S, Gunn HC, Staneva R, Dimova I, Toncheva D. Association of a bitter taste receptor mutation with Balkan Endemic Nephropathy (BEN). BMC Med Genet. 2012;13(1):96.PubMedPubMedCentral
213.
Jelaković B, Dika Ž, Arlt VM, et al. Balkan endemic nephropathy and the causative role of aristolochic acid. In: Seminars in nephrology. Elsevier; p. 284–96.
214.
Deckmann K, Filipski K, Krasteva-Christ G, et al. Bitter triggers acetylcholine release from polymodal urethral chemosensory cells and bladder reflexes. Proc Natl Acad Sci. 2014;111(22):8287–92.PubMedPubMedCentral
215.
Clark AA, Dotson CD, Elson AET, et al. TAS2R bitter taste receptors regulate thyroid function. FASEB J. 2015;29(1):164–72.PubMed
216.
Kimura S, Kato E. TAS2R expression profile in brown adipose, white adipose, skeletal muscle, small intestine, liver and common cell lines derived from mice. Gene Rep. 2020;20: 100763.
217.
Alexandre J, Malheiro R, Dias da Silva D, Carmo H, Carvalho F, Silva JP. The synthetic cannabinoids THJ-2201 and 5F-PB22 enhance in vitro CB1 receptor-mediated neuronal differentiation at biologically relevant concentrations. Int J Mol Sci. 2020;21(17):6277.PubMedCentral
218.
Ning X, He J, Shi X, Yang G. Regulation of adipogenesis by quinine through the ERK/S6 pathway. Int J Mol Sci. 2016;17(4):504.PubMedPubMedCentral
219.
Cancello R, Micheletto G, Meta D, et al. Expanding the role of bitter taste receptor in extra oral tissues: TAS2R38 is expressed in human adipocytes. Adipocyte. 2020;9(1):7–15.PubMedPubMedCentral
220.
Choi J-H. Variation in the TAS2R38 bitterness receptor gene was associated with food consumption and obesity risk in Koreans. Nutrients. 2019;11(9):1973.PubMedCentral
221.
Wölfle U, Elsholz FA, Kersten A, Haarhaus B, Müller WE, Schempp CM. Expression and functional activity of the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes. Skin Pharmacol Physiol. 2015;28(3):137–46.PubMed
222.
Reszka E, Nowakowska-Świrta E, Kupczyk M, et al. Expression of bitter taste receptors in the human skin in vitro. J Clin Res Bioeth. 2015;6(2):1000218.
223.
Shaw L, Mansfield C, Colquitt L, et al. Personalized expression of bitter ‘taste’receptors in human skin. PLoS ONE. 2018;13(10): e0205322.PubMedPubMedCentral
224.
Wölfle U, Haarhaus B, Seiwerth J, et al. The herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivo. Int J Mol Sci. 2017;18(8):1814.PubMedCentral
225.
226.
Wang JC, Hinrichs AL, Bertelsen S, et al. Functional variants in TAS2R38 and TAS2R16 influence alcohol consumption in high-risk families of African-American origin. Alcohol Clin Exp Res. 2007;31(2):209–15.PubMed
227.
Ramos-Lopez O, Roman S, Martinez-Lopez E, et al. Association of a novel TAS2R38 haplotype with alcohol intake among Mexican-Mestizo population. Ann Hepatol. 2015;14(5):729–34.PubMed
228.
Dotson CD, Wallace MR, Bartoshuk LM, Logan HL. Variation in the gene TAS2R13 is associated with differences in alcohol consumption in patients with head and neck cancer. Chem Senses. 2012;37(8):737–44.PubMedPubMedCentral
229.
Duffy VB, Davidson AC, Kidd JR, et al. Bitter receptor gene (TAS2R38), 6-n-propylthiouracil (PROP) bitterness and alcohol intake. Alcohol Clin Exp Res. 2004;28(11):1629–37.PubMedPubMedCentral
230.
Fu D, Riordan S, Kieran S, Andrews RA, Ring HZ, Ring BZ. Complex relationship between TAS2 receptor variations, bitterness perception, and alcohol consumption observed in a population of wine consumers. Food Funct. 2019;10(3):1643–52.PubMed
231.
Pirastu N, Kooyman M, Traglia M, et al. Association analysis of bitter receptor genes in five isolated populations identifies a significant correlation between TAS2R43 variants and coffee liking. PLoS ONE. 2014;9(3): e92065.PubMedPubMedCentral
232.
Ledda M, Kutalik Z, Souza Destito MC, et al. GWAS of human bitter taste perception identifies new loci and reveals additional complexity of bitter taste genetics. Hum Mol Genet. 2014;23(1):259–67.PubMed
233.
234.
Lipchock SV, Spielman AI, Mennella JA, et al. Caffeine bitterness is related to daily caffeine intake and bitter receptor mRNA abundance in human taste tissue. Perception. 2017;46(3–4):245–56.PubMedPubMedCentral
235.
Aoki M, Takao T, Takao K, Koike F, Suganuma N. Lower expressions of the human bitter taste receptor TAS2R in smokers: reverse transcriptase-polymerase chain reaction analysis. Tob Induc Dis. 2014;12(1):12.PubMedPubMedCentral
236.
Mangold JE, Payne TJ, Ma JZ, Chen G, Li MD. Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans. J Med Genet. 2008;45(9):578–82.PubMed
237.
Cannon DS, Baker TB, Piper ME, et al. Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. Nicotine Tob Res. 2005;7(6):853–8.PubMed
238.
Singh N, Chakraborty R, Bhullar RP, Chelikani P. Differential expression of bitter taste receptors in non-cancerous breast epithelial and breast cancer cells. Biochem Biophys Res Commun. 2014;446(2):499–503.PubMed
239.
Jaggupilli A, Singh N, Upadhyaya J, et al. Analysis of the expression of human bitter taste receptors in extraoral tissues. Mol Cell Biochem. 2017;426(1–2):137–47.PubMed
240.
241.
Martin LTP, Nachtigal MW, Selman T, et al. Bitter taste receptors are expressed in human epithelial ovarian and prostate cancers cells and noscapine stimulation impacts cell survival. Mol Cell Biochem. 2019;454(1–2):203–14.PubMed
242.
Zhou J, Gupta K, Yao J, et al. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine. J Biol Chem. 2002;277(42):39777–85.PubMed
243.
Gaida MM, Mayer C, Dapunt U, et al. Expression of the bitter receptor T2R38 in pancreatic cancer: localization in lipid droplets and activation by a bacteria-derived quorum-sensing molecule. Oncotarget. 2016;7(11):12623.PubMedPubMedCentral
244.
Stern L, Giese N, Hackert T, et al. Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10. J Cancer. 2018;9(4):711.PubMedPubMedCentral
245.
Choi J-H, Lee J, Choi IJ, Kim Y-W, Ryu KW, Kim J. Genetic variation in the TAS2R38 bitter taste receptor and gastric cancer risk in Koreans. Sci Rep. 2016;6(1):1–8.
246.
247.
Barontini J, Antinucci M, Tofanelli S, et al. Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer. BMC Gastroenterol. 2017;17(1):104.PubMedPubMedCentral
248.
Bufe B, Breslin PAS, Kuhn C, et al. The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Curr Biol. 2005;15(4):322–7.PubMedPubMedCentral
249.
Choi J-H, Lee J, Oh JH, et al. Variations in the bitterness perception-related genes TAS2R38 and CA6 modify the risk for colorectal cancer in Koreans. Oncotarget. 2017;8(13):21253.PubMedPubMedCentral
250.
Kim U, Wooding S, Ricci D, Jorde LB, Drayna D. Worldwide haplotype diversity and coding sequence variation at human bitter taste receptor loci. Hum Mutat. 2005;26(3):199–204.PubMed
251.
Khare S, Gokulan K, Linthicum DS. Cellular responses of NG108-15 and SK-N-MC lines to sweet and bitter tastants as measured by extracellular acidification rates. J Neurosci Res. 2001;63(1):64–71.PubMed
252.
Lee YH, Song GG. Genome-wide pathway analysis in glioma. Neoplasma. 2015;62(2):230–8.PubMed
253.
Choi J-H, Lee J, Yang S, Lee EK, Hwangbo Y, Kim J. Genetic variations in TAS 2 R3 and TAS 2 R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females. Sci Rep. 2018;8(1):1–11.
254.
Perri A, Catalano S, Bonofiglio D, et al. T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation. Mol Cell Endocrinol. 2014;382(1):205–17.PubMed
255.
Salvestrini V, Ciciarello M, Pensato V, et al. Denatonium as a bitter taste receptor agonist modifies transcriptomic profile and functions of acute myeloid leukemia cells. Front Oncol. 2020;10:1225.PubMedPubMedCentral
256.
Melis M, Errigo A, Crnjar R, Pes GM, Barbarossa IT. TAS2R38 bitter taste receptor and attainment of exceptional longevity. Sci Rep. 2019;9(1):1–9.
257.
Campa D, De Rango F, Carrai M, et al. Bitter taste receptor polymorphisms and human aging. PLoS ONE. 2012;7(11): e45232.PubMedPubMedCentral
258.
Malovini A, Accardi G, Aiello A, et al. Taste receptors, innate immunity and longevity: the case of TAS2R16 gene. Immun Ageing. 2019;16(1):5.PubMedPubMedCentral
259.
Jensen BC, Swigart PM, Simpson PC. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedebergs Arch Pharmacol. 2009;379(4):409.PubMed
260.
Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension. 2013;61(1):253–8.PubMed
261.
Schonbrunn A. Antibody can get it right: confronting problems of antibody specificity and irreproducibility. Oxford: Oxford University Press; 2014.
262.
Behrens M, Born S, Redel U, et al. Immunohistochemical detection of TAS2R38 protein in human taste cells. PLoS ONE. 2012;7(7):e40304.PubMedPubMedCentral
263.
Dżaman K, Zagor M, Sarnowska E, Krzeski A, Kantor I. The correlation of TAS2R38 gene variants with higher risk for chronic rhinosinusitis in Polish patients. Otolaryngol Pol Polish Otolaryngol. 2016;70(5):13–8.
264.
Yang H, Wanner IB, Roper SD, Chaudhari N. An optimized method for in situ hybridization with signal amplification that allows the detection of rare mRNAs. J Histochem Cytochem. 1999;47(4):431–45.PubMed
265.
Jensen E. Technical review: in situ hybridization. Anat Rec. 2014;297(8):1349–53.
266.
Nelson TM, Munger SD, Boughter JD. Haplotypes at the Tas2r locus on distal chromosome 6 vary with quinine taste sensitivity in inbred mice. BMC Genet. 2005;6(1):32.PubMedPubMedCentral
267.
Ozeck M, Brust P, Xu H, Servant G. Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways. Eur J Pharmacol. 2004;489(3):139–49.PubMed
268.
Dando R, Dvoryanchikov G, Pereira E, Chaudhari N, Roper SD. Adenosine enhances sweet taste through A2B receptors in the taste bud. J Neurosci. 2012;32(1):322–30.PubMedPubMedCentral
269.
Brockhoff A, Behrens M, Roudnitzky N, Appendino G, Avonto C, Meyerhof W. Receptor agonism and antagonism of dietary bitter compounds. J Neurosci. 2011;31(41):14775–82.PubMedPubMedCentral
270.
Slack JP, Brockhoff A, Batram C, et al. Modulation of bitter taste perception by a small molecule hTAS2R antagonist. Curr Biol. 2010;20(12):1104–9.PubMedPubMedCentral
271.
Greene TA, Alarcon S, Thomas A, et al. Probenecid inhibits the human bitter taste receptor TAS2R16 and suppresses bitter perception of salicin. PLoS ONE. 2011;6(5): e20123.PubMedPubMedCentral
272.
Roland WSU, Gouka RJ, Gruppen H, et al. 6-Methoxyflavanones as bitter taste receptor blockers for hTAS2R39. PLoS ONE. 2014;9(4): e94451.PubMedPubMedCentral
273.
Rhyu M-R, Kim Y, Misaka T. Suppression of hTAS2R16 signaling by umami substances. Int J Mol Sci. 2020;21(19):7045.PubMedCentral
274.
Pydi SP, Sobotkiewicz T, Billakanti R, Bhullar RP, Loewen MC, Chelikani P. Amino acid derivatives as bitter taste receptor (T2R) blockers. J Biol Chem. 2014;289(36):25054–66.PubMedPubMedCentral
275.
Erdö SL, Wolff JR. γ-Aminobutyric acid outside the mammalian brain. J Neurochem. 1990;54(2):363–72.PubMed
276.
Conte C, Ebeling M, Marcuz A, Nef P, Andres-Barquin PJ. Identification and characterization of human taste receptor genes belonging to the TAS2R family. Cytogenet Genome Res. 2002;98(1):45–53.PubMed
277.
Shi P, Zhang J, Yang H, Zhang Y. Adaptive diversification of bitter taste receptor genes in Mammalian evolution. Mol Biol Evol. 2003;20(5):805–14.PubMed
278.
Mueller KL, Hoon MA, Erlenbach I, Chandrashekar J, Zuker CS, Ryba NJP. The receptors and coding logic for bitter taste. Nature. 2005;434(7030):225–9.PubMed
279.
Ohmoto M, Maeda N, Abe K, Yoshihara Y, Matsumoto I. Genetic tracing of the neural pathway for bitter taste in t2r5-WGA transgenic mice. Biochem Biophys Res Commun. 2010;400(4):734–8.PubMed
280.
Rask-Andersen M, Masuram S, Schiöth HB. The druggable genome: evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication. Annu Rev Pharmacol Toxicol. 2014;54:9–26.PubMed
Metadata
Title
An update on extra-oral bitter taste receptors
Authors
Kamila Tuzim
Agnieszka Korolczuk
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03067-y

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue

Methodology

A versatile web app for identifying the drivers of COVID-19 epidemics

Research

Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities

Research

Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model

Research

A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study

Research

MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis

Research

Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits